Bottom line
How much do IHE and IYH overlap?
43% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 63.8% of IHE's assets and 35.9% of IYH's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings IHE and IYH have in common
| Holding | % of IHE | % of IYH | Overlap |
|---|---|---|---|
| Johnson & Johnson | 22.44% | 10.17% | 10.17% |
| Eli Lilly And Company | 22.25% | 15.11% | 15.11% |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 6.24% | 0.80% | 0.80% |
| Merck & Co., Inc. | 4.55% | 5.31% | 4.55% |
| Bristol-myers Squibb Company | 4.37% | 2.20% | 2.20% |
| Pfizer Inc. | 3.96% | 2.35% | 2.35% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IHE
- Royalty Pharma Plc — 4.34%
- Viatris Inc. — 4.22%
- Zoetis Inc. — 3.73%
- Jazz Pharmaceuticals Public Limited Company — 3.45%
- Elanco Animal Health Incorporated — 2.81%
- Axsome Therapeutics, Inc. — 2.42%
- Corcept Therapeutics Incorporated — 1.90%
- Ligand Pharmaceuticals Incorporated — 1.45%
- Definium Therapeutics Inc — 1.39%
- Liquidia Corp — 1.28%
- Indivior Pharmaceuticals, Inc. — 1.14%
- Crinetics Pharmaceuticals Inc — 0.90%
- Organon & Co. — 0.81%
- Edgewise Therapeutics Inc — 0.70%
- Amneal Pharmaceuticals, Inc. — 0.68%
Only in IYH
- Abbvie Inc. — 7.32%
- Unitedhealth Group Incorporated — 6.16%
- Thermo Fisher Scientific Incorporated — 3.52%
- Amgen Inc. — 3.42%
- Abbott Laboratories — 3.02%
- Gilead Sciences, Inc. — 2.66%
- Intuitive Surgical, Inc. — 2.05%
- Danaher Corporation — 2.03%
- Vertex Pharmaceuticals Incorporated — 2.00%
- Stryker Corporation — 1.86%
- Medtronic Public Limited Company — 1.80%
- Elevance Health, Inc. — 1.34%
- Regeneron Pharmaceuticals, Inc. — 1.27%
- The Cigna Group — 1.20%
- Boston Scientific Corporation — 1.14%
Asset mix
| Asset type | IHE | IYH |
|---|---|---|
| Stocks | 99.9% | 99.8% |
| Cash & short-term funds | 6.3% | 0.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | IHE | IYH |
|---|---|---|
| US | 96.4% | 97.3% |
| GB | 4.3% | 0.4% |
| IE | 3.8% | 2.4% |
| CA | 1.4% | — |
| BM | — | 0.3% |
| SG | 0.2% | — |
| DK | — | 0.2% |
| KY | 0.2% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do IHE and IYH overlap?
What stocks do IHE and IYH have in common?
Should I own both IHE and IYH?
Which holds more stocks, IHE or IYH?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.